会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明授权
    • Encoder system, a decoder system, a coding/decoding apparatus, an encoding method and a decoding method
    • 编码器系统,解码器系统,编码/解码装置,编码方法和解码方法
    • US07376881B2
    • 2008-05-20
    • US11132862
    • 2005-05-19
    • Chang Qing XuMasayuki Tomisawa
    • Chang Qing XuMasayuki Tomisawa
    • H04L1/18H03M13/03
    • H03M13/3905H03M13/23H03M13/2957H03M13/41H03M13/6516
    • An encoder system for encoding a signal according to any number of FEC and/or channel codes comprises a shift register, an array of MOD/XOR stages, and a generator matrix stage for controlling the connections between the shift register and the MOD/XOR stages and altering these connections according to a coding format selected by an encoder selection stage. There is also disclosed a decoder system for decoding a signal encoded according to a number of FEC and/or channel codes comprising a decoding stage, and a generator matrix stage for configuring the decoding stage to a decoding code format to be applied an incoming encoded signal. A decoder selection stage is coupled to the generator matrix stage and selects the decoding code format to be used in the decoding process. The decoder selection stage instructs the generator matrix stage to configure the decoding stage according to the selected decoding code format. There is also disclosed a method for encoding and decoding.
    • 用于根据任何数量的FEC和/或信道码编码信号的编码器系统包括移位寄存器,MOD / XOR级的阵列和用于控制移位寄存器和MOD / XOR级之间的连接的发生器矩阵级 以及根据由编码器选择级选择的编码格式来改变这些连接。 还公开了一种解码器系统,用于对根据包含解码级的FEC和/或信道码的数量编码的信号进行解码,以及用于将解码级配置为应用输入编码信号的解码级的发生器矩阵级 。 解码器选择级耦合到发生器矩阵级,并选择要在解码过程中使用的解码码格式。 解码器选择阶段指示发生器矩阵级根据选择的解码码格式配置解码级。 还公开了一种编码和解码方法。
    • 74. 发明申请
    • Sh2 domain binding inhibitors
    • Sh2结构域结合抑制剂
    • US20060167222A1
    • 2006-07-27
    • US10517717
    • 2003-06-26
    • Terrence BurkeChang-Qing WeiZhen-DaN ShiYang Gao
    • Terrence BurkeChang-Qing WeiZhen-DaN ShiYang Gao
    • C07K5/12C07D245/02
    • C07F9/6515C07K5/06026C07K5/06191
    • Disclosed are compounds for SH2 domain binding inhibition, for example, a compound of formula (I), wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; R3 is hydrogen, azido, amino, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, or alkylcarbonylamino, wherein the alkyl portion of R3 may be optionally substituted with a substituent selected from the group consisting of halo, hydroxy, carboxyl, amino, aminoalkyl, alkyl, alkoxy, and keto; R6 is a linker; AA is an amino acid; and n is 1 to 6; or a salt thereof. The conformationally compounds provide enhanced binding affinity with SH2 domain protein. Also disclosed are a pharmaceutical compositions and a method for inhibiting an SH2 domain from binding with a phosphoprotein.
    • 公开了用于SH2结构域结合抑制的化合物,例如式(I)的化合物,其中R 1是亲脂体; R 2与苯环组合是苯基磷酸酯模拟基团或被保护的苯基磷酸酯模拟基团; R 3是氢,叠氮基,氨基,羧基烷基,烷氧基羰基烷基,氨基羰基烷基或烷基羰基氨基,其中R 3的烷基部分可以任选地被选自 由卤素,羟基,羧基,氨基,氨基烷基,烷基,烷氧基和酮基组成; R 6是连接体; AA是氨基酸; n为1〜6; 或其盐。 构象化合物提供与SH2结构域蛋白质增强的结合亲和力。 还公开了用于抑制SH2结构域与磷蛋白结合的药物组合物和方法。
    • 75. 发明授权
    • Wavelength conversion element and method for using same
    • 波长转换元件及其使用方法
    • US07034990B2
    • 2006-04-25
    • US10925011
    • 2004-08-25
    • Takeshi KamijohChang-qing Xu
    • Takeshi KamijohChang-qing Xu
    • G02F1/35G02F1/39
    • G02F1/3536G02F2001/3548
    • A wavelength conversion element which can set the wavelength of a pump light to a wavelength longer or shorter than the wavelength of a plurality of signal lights and a wavelength of a plurality of conversion lights present in an optical communication band, and a method for using such a wavelength conversion element are provided. A first pump light with a wavelength λ1 of 1.51 μm, a second pump light with a wavelength λ2 of 1.57 μm, and a signal light with a wavelength of λS of 1.55 μm are multiplexed in a multiplexer and introduced as an incident light into an optical waveguide of a wavelength conversion element. In the optical waveguide, an SF light with a wavelength λSF of 0.77 μm is generated by the SFG of the first pump light with a wavelength λ1 of 1.51 μm and the second pump light with a wavelength λ2 of 1.57 μm, the signal light is wavelength converted as a DF light (wavelength 1.53 μm) by the DFG of the SF light and signal light, and this DF light is outputted as the converted light (wavelength λC=1.53 μm).
    • 一种波长转换元件,其可将泵浦光的波长设定为比多个信号光的波长长的或短于波长的光波长,以及存在于光通信带中的多个转换光的波长,以及使用该波长的方法 提供波长转换元件。 具有1.51μm波长λ<1> 1的第一泵浦光,波长为λ<2>1.5μm的第二泵浦光和波长为λ< 在多路复用器中复用1.55μm的子信号,并将其作为入射光引入到波长转换元件的光波导中。 在光波导中,具有0.77μm波长λ SF 的SF光由波长λ1> 1.51的第一泵浦光的SFG产生,并且 第二泵浦光的波长λ<2 1.57μm,信号光通过SF光和信号光的DFG被波长转换为DF光(波长1.53μm),该DF光为 作为转换光(波长λC =1.53μm)输出。
    • 77. 发明授权
    • Feeding system for semi-solid metal injection
    • 半固体金属注射进料系统
    • US08327914B2
    • 2012-12-11
    • US12786936
    • 2010-05-25
    • Chang-Qing ZhengFlorentin Laplume
    • Chang-Qing ZhengFlorentin Laplume
    • B22D17/04B22D23/00
    • B22D17/007B22D17/2023
    • A semi-solid metal alloy injection feed system for reduced inclusion injection molding comprises a substantially closed injection chamber for containing a billet of semi-solid metal alloy, and thrusting the billet through the injection chamber into a mold, wherein the injection chamber has a first section defined by a wall with an inner contour for mating with a bearing surface for reciprocating motion of the bearing surface within the first section, along a center axis of the injection chamber; and the injection chamber has an outlet in fluid communication with the mold, the outlet provided at an opening in the injection chamber that is offset with respect to the center axis, and is disposed at an angle of 90° to 125° from the center axis. There is no neck or throttling between the chamber and the outlet. A butt end trap is preferably formed that requires inclusions that are principally on a bottom side of the injector to travel a relatively long ways to enter the outlet.
    • 用于减少夹杂物注射成型的半固体金属合金注射进料系统包括用于容纳半固体金属合金坯料的基本封闭的注射室,并将坯料通过注射室推入模具,其中注射室具有第一 由具有用于与轴承表面配合的内部轮廓的壁限定,用于沿着所述注射室的中心轴线在所述第一部分内的所述支承表面的往复运动; 并且所述注射室具有与所述模具流体连通的出口,所述出口设置在所述注射室中的相对于所述中心轴线偏移的开口处,并且设置成与所述中心轴线成90°至125°的角度 。 室和出口之间没有颈部或节流。 优选地形成对接端陷阱,其需要主要位于喷射器的底侧上的夹杂物以相对较长的方式行进以进入出口。
    • 79. 发明申请
    • System and Method for Making a User Dependent Language Model
    • 制作用户依赖语言模型的系统和方法
    • US20100145677A1
    • 2010-06-10
    • US12396933
    • 2009-03-03
    • Chang-Qing Shu
    • Chang-Qing Shu
    • G06F17/27G06F17/30
    • G06F16/313
    • A language model for a speech recognition engine is made based on user-viewed data files. The data files are reviewed and texts are extracted therefrom. The language model is generated based on the extracted texts. Transcriptions of previous user statements are not required. Different weighting factors can be applied to elements of the extracted texts based on the nature of the data files. The weighting factors are then considered during generation of the language model. A user dependent and application independent language model can be created prior to initial use of the speech recognition engine.
    • 语音识别引擎的语言模型基于用户观看的数据文件进行。 审查数据文件并从中提取文本。 语言模型基于提取的文本生成。 以前的用户语句的转录不是必需的。 基于数据文件的性质,可以将不同的加权因子应用于提取文本的元素。 然后在语言模型的生成期间考虑加权因子。 可以在语音识别引擎的初始使用之前创建用户依赖的和与应用无关的语言模型。
    • 80. 发明授权
    • SH2 domain binding inhibitors
    • SH2结构域结合抑制剂
    • US07425537B2
    • 2008-09-16
    • US10517717
    • 2003-06-26
    • Terrence R Burke, Jr.Chang-Qing WeiZhen-Dan ShiYang Gao
    • Terrence R Burke, Jr.Chang-Qing WeiZhen-Dan ShiYang Gao
    • A61K38/12C07K5/12C07K1/00
    • C07F9/6515C07K5/06026C07K5/06191
    • Disclosed are compounds for SH2 domain binding inhibition, for example, a compound of formula (I), wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; R3 is hydrogen, azido, amino, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, or alkylcarbonylamino, wherein the alkyl portion of R3 may be optionally substituted with a substituent selected from the group consisting of halo, hydroxy, carboxyl, amino, aminoalkyl, alkyl, alkoxy, and keto; R6 is a linker; AA is an amino acid; and n is 1 to 6; or a salt thereof. The conformationally compounds provide enhanced binding affinity with SH2 domain protein. Also disclosed are a pharmaceutical compositions and a method for inhibiting an SH2 domain from binding with a phosphoprotein.
    • 公开了用于SH2结构域结合抑制的化合物,例如式(I)的化合物,其中R 1是亲脂体; R 2与苯环组合是苯基磷酸酯模拟基团或被保护的苯基磷酸酯模拟基团; R 3是氢,叠氮基,氨基,羧基烷基,烷氧基羰基烷基,氨基羰基烷基或烷基羰基氨基,其中R 3的烷基部分可以任选地被选自 由卤素,羟基,羧基,氨基,氨基烷基,烷基,烷氧基和酮基组成; R 6是连接体; AA是氨基酸; n为1〜6; 或其盐。 构象化合物提供与SH2结构域蛋白质增强的结合亲和力。 还公开了用于抑制SH2结构域与磷蛋白结合的药物组合物和方法。